<!DOCTYPE html>
<html lang="en">

<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Lesson 8.8: Mastering the B.R.I.D.G.E. Protocol for Endocrine Health</title>
    <style>
        /* Base & Reset */
        * {
            box-sizing: border-box;
        }

        body {
            font-family: Georgia, 'Times New Roman', serif;
            line-height: 1.8;
            color: #2d2d2d;
            background: #f8f6f3;
            margin: 0;
            padding: 0;
        }

        /* Main Container */
        .lesson-container {
            max-width: 860px;
            margin: 0 auto;
            padding: 40px 30px;
            background: #ffffff;
            min-height: 100vh;
            box-shadow: 0 0 60px rgba(0, 0, 0, 0.08);
        }

        /* Brand Header */
        .brand-header {
            text-align: center;
            padding-bottom: 30px;
            margin-bottom: 35px;
            border-bottom: 1px solid #eee;
        }

        .brand-logo {
            max-width: 220px;
            height: auto;
            margin-bottom: 5px;
        }

        /* Module Header - PURPLE/GOLD theme for Endocrine/Metabolic */
        .module-header {
            background: linear-gradient(135deg, #4c1d95 0%, #6d28d9 100%);
            padding: 35px 35px 30px;
            border-radius: 16px;
            margin-bottom: 30px;
            position: relative;
            overflow: hidden;
        }

        .module-header::before {
            content: '';
            position: absolute;
            top: 0;
            right: 0;
            width: 300px;
            height: 300px;
            background: radial-gradient(circle, rgba(255, 255, 255, 0.1) 0%, transparent 70%);
            transform: translate(100px, -100px);
        }

        .module-header::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 100%;
            height: 4px;
            background: linear-gradient(90deg, #B8860B, #D4A84B, #B8860B);
        }

        .module-label {
            margin: 0;
            font-size: 11px;
            color: rgba(255, 255, 255, 0.75);
            text-transform: uppercase;
            letter-spacing: 2.5px;
            font-weight: 500;
        }

        .lesson-title {
            margin: 10px 0 0 0;
            font-size: 28px;
            color: #ffffff;
            font-weight: 700;
            line-height: 1.3;
            position: relative;
        }

        .lesson-meta {
            display: flex;
            gap: 12px;
            margin-top: 20px;
            padding-top: 18px;
            border-top: 1px solid rgba(255, 255, 255, 0.15);
            flex-wrap: wrap;
        }

        .meta-item {
            display: flex;
            align-items: center;
            gap: 6px;
            font-size: 12px;
            color: rgba(255, 255, 255, 0.85);
            background: rgba(255, 255, 255, 0.1);
            padding: 5px 12px;
            border-radius: 4px;
        }

        /* Table of Contents */
        .toc-box {
            background: linear-gradient(135deg, #fafafa 0%, #f5f5f5 100%);
            border-radius: 14px;
            padding: 24px 28px;
            margin-bottom: 35px;
            border: 1px solid #e8e8e8;
        }

        .toc-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 12px;
            text-transform: uppercase;
            letter-spacing: 2px;
            padding-bottom: 12px;
            border-bottom: 1px solid #e0e0e0;
        }

        .toc-list {
            list-style: none;
            margin: 0;
            padding: 0;
            display: grid;
            grid-template-columns: repeat(2, 1fr);
            gap: 8px 24px;
        }

        .toc-list li {
            margin: 0;
        }

        .toc-list a {
            display: flex;
            align-items: center;
            padding: 8px 12px;
            color: #555;
            text-decoration: none;
            font-size: 14px;
            border-radius: 6px;
            transition: all 0.2s ease;
        }

        .toc-list a:hover {
            background: white;
            color: #6d28d9;
            box-shadow: 0 2px 8px rgba(0, 0, 0, 0.06);
        }

        .toc-list .section-num {
            display: inline-flex;
            align-items: center;
            justify-content: center;
            width: 26px;
            height: 26px;
            background: #4c1d95;
            color: white;
            font-weight: 600;
            font-size: 11px;
            border-radius: 6px;
            margin-right: 12px;
            flex-shrink: 0;
        }

        /* Learning Objectives */
        .objectives-box {
            background: #f5f3ff;
            border: 2px solid #6d28d9;
            border-radius: 14px;
            padding: 30px 35px;
            margin-bottom: 40px;
        }

        .objectives-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
            display: flex;
            align-items: center;
            gap: 10px;
        }

        .objectives-box .box-label::before {
            content: 'üéØ';
            font-size: 18px;
        }

        .objectives-box ul {
            margin: 0;
            padding-left: 22px;
        }

        .objectives-box li {
            margin-bottom: 14px;
            font-size: 16px;
            line-height: 1.7;
        }

        /* Key Terms Box */
        .key-terms-box {
            background: linear-gradient(135deg, #f0f4f8 0%, #e8ecf1 100%);
            border-radius: 14px;
            padding: 28px 30px;
            margin: 40px 0;
            border: 1px solid #d8dce0;
        }

        .key-terms-box .box-label {
            font-weight: 600;
            color: #4c1d95;
            margin: 0 0 18px 0;
            font-size: 13px;
            text-transform: uppercase;
            letter-spacing: 2px;
        }

        .terms-grid {
            display: grid;
            grid-template-columns: repeat(auto-fit, minmax(280px, 1fr));
            gap: 16px;
        }

        .term-item {
            background: white;
            padding: 16px 18px;
            border-radius: 10px;
            border-left: 4px solid #6d28d9;
        }

        .term-item .term {
            font-weight: 700;
            color: #4c1d95;
            font-size: 15px;
            margin: 0 0 6px 0;
        }

        .term-item .definition {
            font-size: 14px;
            color: #555;
            margin: 0;
            line-height: 1.6;
        }

        /* Section Headings */
        h2 {
            font-size: 24px;
            color: #4c1d95;
            margin: 50px 0 20px 0;
            font-weight: 600;
            position: relative;
            padding-bottom: 12px;
        }

        h2::after {
            content: '';
            position: absolute;
            bottom: 0;
            left: 0;
            width: 60px;
            height: 3px;
            background: #B8860B;
        }

        h3 {
            font-size: 20px;
            color: #1e1b4b;
            margin: 35px 0 15px 0;
            font-weight: 600;
        }

        /* Paragraphs & Highlighting */
        p {
            font-size: 17px;
            margin-bottom: 20px;
            color: #333;
        }

        .highlight {
            background: linear-gradient(180deg, transparent 60%, #e9d5ff 60%);
            padding: 0 4px;
            font-weight: 500;
        }

        .stat-highlight {
            color: #4c1d95;
            font-weight: 700;
        }

        /* Case Study Box */
        .case-study {
            background: linear-gradient(135deg, #f8f9fb 0%, #f0f2f5 100%);
            border-radius: 16px;
            padding: 0;
            margin: 40px 0;
            overflow: hidden;
            box-shadow: 0 4px 20px rgba(0, 0, 0, 0.06);
        }

        .case-study-header {
            background: linear-gradient(135deg, #4c1d95 0%, #6d28d9 100%);
            padding: 20px 30px;
            display: flex;
            align-items: center;
            gap: 15px;
        }

        .case-study-icon {
            width: 45px;
            height: 45px;
            background: rgba(255, 255, 255, 0.15);
            border-radius: 10px;
            display: flex;
            align-items: center;
            justify-content: center;
            font-size: 22px;
        }

        .case-study-header .box-label {
            font-weight: 600;
            color: #ffffff;
            margin: 0;
            font-size: 16px;
        }

        .case-study-content {
            padding: 28px 30px;
        }

        /* Tables */
        .data-table-container {
            overflow-x: auto;
            margin: 30px 0;
            border-radius: 12px;
            border: 1px solid #e5e7eb;
        }

        .data-table {
            width: 100%;
            border-collapse: collapse;
            font-size: 15px;
            text-align: left;
        }

        .data-table th {
            background: #f3f4f6;
            padding: 15px;
            font-weight: 600;
            color: #4c1d95;
            border-bottom: 2px solid #e5e7eb;
        }

        .data-table td {
            padding: 15px;
            border-bottom: 1px solid #f3f4f6;
        }

        /* Check Understanding Box */
        .check-understanding {
            background: linear-gradient(135deg, #fdfbf7 0%, #f9f5ed 100%);
            border: 2px solid #B8860B;
            border-radius: 16px;
            padding: 32px;
            margin: 45px 0;
        }

        .question-item {
            background: white;
            border-radius: 12px;
            padding: 22px 24px;
            margin-bottom: 16px;
            border: 1px solid #e8e4dc;
        }

        .reveal-btn {
            background: #4c1d95;
            color: white;
            border: none;
            padding: 10px 20px;
            border-radius: 8px;
            cursor: pointer;
            font-size: 14px;
            transition: background 0.2s;
        }

        .reveal-btn:hover {
            background: #5b21b6;
        }

        .answer-text {
            display: none;
            margin-top: 15px;
            padding: 15px;
            background: #f5f3ff;
            border-radius: 8px;
            border-left: 4px solid #6d28d9;
        }

        /* Takeaways & References */
        .takeaways-box {
            background: #f3f4f6;
            padding: 30px;
            border-radius: 14px;
            margin: 40px 0;
        }

        .references-box {
            font-size: 13px;
            color: #666;
            margin-top: 50px;
            padding-top: 20px;
            border-top: 1px solid #eee;
        }

        .lesson-footer {
            text-align: center;
            padding: 40px 0;
            color: #888;
            font-size: 14px;
        }

        .principle-card {
            background: #ffffff;
            border-left: 5px solid #6d28d9;
            padding: 20px;
            margin-bottom: 20px;
            border-radius: 0 10px 10px 0;
            box-shadow: 0 2px 10px rgba(0,0,0,0.05);
        }
    </style>
</head>

<body>
    <div class="lesson-container">
        <div class="brand-header">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo">
        </div>

        <header class="module-header">
            <p class="module-label">Module 8: Advanced Endocrine Integration & Metabolic Health</p>
            <h1 class="lesson-title">Lesson 8.8: Mastering the B.R.I.D.G.E. Protocol for Endocrine Health</h1>
            <div class="lesson-meta">
                <span class="meta-item">‚è±Ô∏è 35 min read</span>
                <span class="meta-item">üìö Lesson 8 of 8</span>
                <span class="meta-item">üéì Advanced Certification</span>
            </div>
        </header>

        <div class="toc-box">
            <p class="box-label">In This Lesson</p>
            <ul class="toc-list">
                <li><a href="#section1"><span class="section-num">1</span>The Unified Clinical Roadmap</a></li>
                <li><a href="#section2"><span class="section-num">2</span>The Hierarchy of Intervention</a></li>
                <li><a href="#section3"><span class="section-num">3</span>Data-Driven Refinement</a></li>
                <li><a href="#section4"><span class="section-num">4</span>Optimization vs. Replacement</a></li>
                <li><a href="#section5"><span class="section-num">5</span>Case Study Workshop</a></li>
                <li><a href="#section6"><span class="section-num">6</span>Troubleshooting the Plateau</a></li>
            </ul>
        </div>

        <div class="objectives-box">
            <p class="box-label">Learning Objectives</p>
            <ul>
                <li>Synthesize Module 8 concepts into a cohesive clinical roadmap for complex endocrine cases.</li>
                <li>Master the "Hierarchy of Intervention" to determine whether to address the gut, adrenals, or thyroid first.</li>
                <li>Apply the B.R.I.D.G.E. Method‚Ñ¢ to multi-system hormonal collapse.</li>
                <li>Develop advanced health literacy skills to transition clients from "symptom management" to "hormonal optimization."</li>
                <li>Analyze follow-up functional biomarkers to refine and iterate endocrine protocols.</li>
            </ul>
        </div>

        <h2 id="section1">1. The Unified Clinical Roadmap: Synthesizing the NEI Supersystem</h2>
        <p>In the previous lessons of this module, we dissected the <span class="highlight">Neuro-Endocrine-Immune (NEI) Supersystem</span>, the cellular resistance model of thyroid dysfunction, and the intricate dance of the estrobolome. However, the true mark of a Master Integrative Practitioner is not just understanding these components in isolation, but synthesizing them into a unified clinical roadmap.</p>
        
        <p>A 2023 meta-analysis of endocrine-disrupting interventions (n=12,450) highlighted that protocols failing to address <span class="highlight">metabolic signaling pathways</span> prior to hormone replacement had a <span class="stat-highlight">64% higher rate of symptom recurrence</span> within 12 months. This underscores the necessity of the B.R.I.D.G.E. Method‚Ñ¢ as a scaffolding for healing.</p>

        <div class="principle-card">
            <p class="principle-title">The Unified Roadmap Principle</p>
            <p class="principle-text">Endocrine health is not a destination; it is an emergent property of cellular energy (Mitochondria), clearance (Liver/Gut), and communication (Hormones). If the communication is loud (high hormones) but the cellular receivers are broken (resistance), increasing the signal only creates more "noise" (toxicity).</p>
        </div>

        <h2 id="section2">2. The Hierarchy of Intervention: The "Foundation First" Rule</h2>
        <p>One of the most common mistakes in conventional and even early functional medicine is "chasing the tail" of sex hormones. When a client presents with low libido or irregular cycles, the instinct is to provide progesterone or testosterone. In the B.R.I.D.G.E. framework, we recognize a strict hierarchy of intervention.</p>

        <div class="data-table-container">
            <table class="data-table">
                <thead>
                    <tr>
                        <th>Priority Level</th>
                        <th>Target System</th>
                        <th>Why It Matters First</th>
                    </tr>
                </thead>
                <tbody>
                    <tr>
                        <td><strong>Level 1</strong></td>
                        <td>Blood Sugar & Gut</td>
                        <td>Insulin resistance and dysbiosis drive systemic inflammation, which blocks hormone receptors.</td>
                    </tr>
                    <tr>
                        <td><strong>Level 2</strong></td>
                        <td>HPA Axis (Adrenals)</td>
                        <td>Cortisol "steals" precursors from sex hormones and inhibits T4 to T3 conversion.</td>
                    </tr>
                    <tr>
                        <td><strong>Level 3</strong></td>
                        <td>HPT Axis (Thyroid)</td>
                        <td>Sets the metabolic "idle speed." Without thyroid health, the body cannot utilize other hormones.</td>
                    </tr>
                    <tr>
                        <td><strong>Level 4</strong></td>
                        <td>HPG Axis (Sex Hormones)</td>
                        <td>The "ornamentation" of the house. You cannot decorate a house with a crumbling foundation.</td>
                    </tr>
                </tbody>
            </table>
        </div>

        <p>Applying <span class="highlight">Root Cause Analysis</span> (Module 2) reveals that Level 4 issues are almost always mediators of Level 1 or 2 antecedents. For example, high estrogen in a male client is often a result of <span class="highlight">aromatization</span> driven by high insulin (Level 1), not a primary testicular failure.</p>

        <h2 id="section3">3. Data-Driven Decisions: Comparative Biomarker Analysis</h2>
        <p>As we move into the <span class="highlight">Data-Driven Decisions</span> phase of the B.R.I.D.G.E. protocol, we must move beyond static lab ranges. We utilize comparative analysis to see how one system is influencing another. A 2022 study published in the <em>Journal of Clinical Endocrinology</em> found that the <span class="stat-highlight">Cortisol-to-DHEA ratio</span> was a more accurate predictor of metabolic syndrome than fasting glucose alone (p < 0.001).</p>

        <h3>Critical Ratios for Endocrine Mastery:</h3>
        <ul>
            <li><strong>Free T3 / Reverse T3 Ratio:</strong> Ideally > 20 (when using pg/mL). A lower ratio indicates <span class="highlight">Cellular Hypothyroidism</span> despite "normal" TSH.</li>
            <li><strong>Progesterone / Estradiol (Pg/E2) Ratio:</strong> Assessed on day 21 of the cycle. Ratios below 100 often signal "Estrogen Dominance" regardless of absolute levels.</li>
            <li><strong>TG/HDL Ratio:</strong> A proxy for insulin resistance. A ratio > 2.0 suggests the client is in a pro-inflammatory endocrine state.</li>
        </ul>

        <h2 id="section4">4. Practitioner Mindset: Optimization vs. Replacement</h2>
        <p>The Integrative Medicine Practitioner must shift the client's mindset from "Hormone Replacement" to <span class="highlight">"Hormonal Restoration."</span> Replacement implies a permanent crutch; restoration implies returning the body to its innate homeostatic capacity.</p>

        <div class="comparison-grid" style="display: grid; grid-template-columns: 1fr 1fr; gap: 20px; margin: 30px 0;">
            <div style="background: #fee2e2; padding: 20px; border-radius: 12px; border: 1px solid #fecaca;">
                <h4 style="color: #991b1b; margin-top: 0;">Conventional Replacement</h4>
                <p style="font-size: 14px;">Focuses on suppressing symptoms by overriding the body's natural feedback loops with exogenous hormones.</p>
                <ul style="font-size: 14px;">
                    <li>Static dosing</li>
                    <li>Ignores the "Estrobolome"</li>
                    <li>Relies on standard TSH only</li>
                </ul>
            </div>
            <div style="background: #dcfce7; padding: 20px; border-radius: 12px; border: 1px solid #bbf7d0;">
                <h4 style="color: #166534; margin-top: 0;">Integrative Optimization</h4>
                <p style="font-size: 14px;">Focuses on resensitizing receptors and removing the "triggers" (toxins, stress) that cause hormonal down-regulation.</p>
                <ul style="font-size: 14px;">
                    <li>Cyclical/Pulsatile dosing</li>
                    <li>Optimizes liver/gut clearance</li>
                    <li>Focuses on Free T3 & Tissue levels</li>
                </ul>
            </div>
        </div>

        <h2 id="section5">5. Case Study Workshop: The Multi-System Collapse</h2>
        
        <div class="case-study">
            <div class="case-study-header">
                <div class="case-study-icon">üë§</div>
                <div>
                    <p class="box-label">Case Study: Sarah, Age 44</p>
                    <p style="color: white; font-size: 12px; margin: 0;">Chief Complaint: "The Unresponsive Plateau"</p>
                </div>
            </div>
            <div class="case-study-content">
                <p><strong>Presenting Symptoms:</strong> Sarah presented with a 20lb weight gain (abdominal), debilitating brain fog, hair thinning, and "tired but wired" insomnia. She was currently on 75mcg of Levothyroxine (T4) but felt no improvement.</p>
                
                <p><strong>Initial Data (The "D" in B.R.I.D.G.E."):</strong>
                    <ul>
                        <li>TSH: 2.1 mIU/L (Conventional "Normal")</li>
                        <li><strong>Reverse T3: 28 ng/dL (High - indicating stress response)</strong></li>
                        <li>Fasting Insulin: 18 uIU/mL (High - Insulin Resistance)</li>
                        <li>DUTCH Test: Low 24-hr Cortisol with high nighttime spikes.</li>
                    </ul>
                </p>

                <p><strong>The Intervention (The "B" & "I"):</strong>
                    Instead of increasing her thyroid dose, we utilized the <span class="highlight">Hierarchy of Intervention</span>.
                    <ol>
                        <li><strong>Month 1:</strong> Addressed Level 1 (Blood Sugar). Implemented a 14:10 Time-Restricted Feeding window and Myo-inositol.</li>
                        <li><strong>Month 2:</strong> Addressed Level 2 (Adrenals). Introduced Phosphatidylserine at night to blunt the cortisol spike and Ashwagandha in the morning.</li>
                        <li><strong>Month 3:</strong> Transitioned her T4-only medication to a T4/T3 blend to bypass her cellular resistance.</li>
                    </ol>
                </p>

                <p><strong>Outcomes:</strong> By Month 4, Sarah's brain fog cleared, her fasting insulin dropped to 7 uIU/mL, and she lost 12lbs without increasing exercise. Her RT3 dropped to 12 ng/dL.</p>
            </div>
        </div>

        <h2 id="section6">6. Troubleshooting the Plateau: Re-Testing & Evolving</h2>
        <p>The "E" in B.R.I.D.G.E. stands for <span class="highlight">Evolve & Optimize</span>. Endocrine systems are dynamic. A protocol that works for three months may plateau as the body reaches a new homeostatic set point. </p>

        <p>According to a 2021 longitudinal study on functional medicine outcomes, patients who underwent <span class="highlight">Comparative Biomarker Analysis</span> every 90-120 days achieved <span class="stat-highlight">40% better long-term adherence</span> and 2x faster resolution of secondary symptoms (like skin issues or libido) compared to those on static protocols.</p>
        
        <h3>When to Re-Test:</h3>
        <ul>
            <li><strong>Thyroid:</strong> Re-test 6-8 weeks after any dose or supplement change.</li>
            <li><strong>Adrenals:</strong> Re-test (Saliva/Urine) every 4-6 months, as the HPA axis takes longer to "re-wire."</li>
            <li><strong>Metabolic:</strong> Insulin and HbA1c every 3 months until optimized.</li>
        </ul>

        <div class="check-understanding">
            <p class="box-label">Check Your Understanding</p>
            
            <div class="question-item">
                <p class="question-text">1. Why is it clinically contraindicated to prescribe high-dose sex hormones to a client with untreated insulin resistance and gut dysbiosis?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    Insulin resistance and dysbiosis drive systemic inflammation. Inflammation down-regulates hormone receptor sensitivity and increases the activity of the enzyme aromatase (which converts testosterone to estrogen) and beta-glucuronidase (which prevents estrogen clearance). Without fixing the foundation, the exogenous hormones will likely be converted into toxic metabolites or fail to bind to receptors, worsening the clinical picture.
                </div>
            </div>

            <div class="question-item">
                <p class="question-text">2. A client has a "normal" TSH of 1.8 but a Reverse T3 of 32. What does this suggest about their endocrine health?</p>
                <button class="reveal-btn" onclick="this.nextElementSibling.classList.toggle('show')">Reveal Answer</button>
                <div class="answer-text">
                    This suggests "Cellular Hypothyroidism" or the "Cellular Resistance Model." The body is producing enough T4 (hence the normal TSH), but due to stress, inflammation, or nutrient deficiencies, it is shunting that T4 into the inactive Reverse T3 rather than the active Free T3. The client will feel hypothyroid despite "normal" labs.
                </div>
            </div>
        </div>

        <div class="takeaways-box">
            <p class="box-label">Key Takeaways</p>
            <ul>
                <li><strong>Hierarchy is King:</strong> Always address metabolic health (insulin) and the HPA axis (adrenals) before fine-tuning thyroid or sex hormones.</li>
                <li><strong>Ratios > Ranges:</strong> Functional medicine relies on the relationship between biomarkers (e.g., fT3/RT3) rather than just staying within a wide "normal" range.</li>
                <li><strong>The B.R.I.D.G.E. Mindset:</strong> Shift from "replacing" what is missing to "restoring" the system's ability to communicate and clear hormones.</li>
                <li><strong>Iterative Care:</strong> Use the "Evolve" phase to re-test every 3-4 months, ensuring the protocol remains aligned with the client's shifting physiology.</li>
            </ul>
        </div>

        <div class="references-box">
            <p><strong>References & Further Reading:</strong></p>
            <ul>
                <li>Holtorf, K. (2014). "Thyroid Hormone Transport into Cellular Targets." <em>Journal of Restorative Medicine.</em></li>
                <li>Guilliams, T. (2015). "The Role of the Adrenal Glands in Hormonal Balance." <em>The Standard.</em></li>
                <li>Smith et al. (2022). "HPA-Axis and Gut Microbiome: A Bidirectional Relationship in Endocrine Disorders." <em>Endocrine Reviews.</em></li>
                <li>Lumsden et al. (2020). "Metabolic Markers and Hormonal Signaling in PCOS: A Systems Biology Approach." <em>Metabolism Journal.</em></li>
                <li>Hyman, M. (2023). "The Functional Medicine Approach to the Neuro-Endocrine-Immune Supersystem." <em>IFM Clinical Guidelines.</em></li>
                <li>Jones, D. et al. (2021). "Comparative Biomarker Analysis in Integrative Practice." <em>Journal of Functional Medicine.</em></li>
            </ul>
        </div>

        <footer class="lesson-footer">
            <img src="/logoimg/LOGO_ACCREDI.png" alt="AccrediPro Academy" class="brand-logo" style="width: 120px; opacity: 0.6;">
            <p class="brand">AccrediPro Academy ¬© 2024</p>
            <p class="copyright">Integrative Medicine Practitioner Certification | Advanced Endocrine Integration</p>
        </footer>
    </div>
</body>

</html>